Hologic’s Sustainability Commitment Continues to Grow Worldwide

February 29, 2024

MARLBOROUGH, Mass., February 29, 2024 — Hologic, Inc.’s (Nasdaq: HOLX) leadership in championing the health of women, their families and their communities continues to expand globally — as shown in the company’s new sustainability report titled “Our Commitment Knows No Bounds.”

The annual report spotlights how Hologic leverages its financial strength, derived from its innovative medical technologies, to increasingly elevate the well-being of women. It features a wide range of social responsibility efforts, including providing unique data on the state of women’s health worldwide, giving philanthropic support to hundreds of nonprofit organizations and forging key partnerships to underscore the importance of making preventive care a top priority.

“We strive to exemplify the societal benefits private enterprise can drive with a thoughtful, courageous and unconventional approach to everything we do. These words are embedded into the very fiber of our culture,” said Hologic Chairman, President and CEO Stephen P. MacMillan.

This culture comes to life because of Hologic’s approximately 7,000 highly engaged team members from across the continents. The company ranks in the 97th percentile of employee engagement among similar-sized employers worldwide, earning Gallup’s top workplace award for the past three years. Hologic also has received nearly two dozen other awards for workplace excellence, world-changing ideas and other aspects of sustainability from independent evaluators such as the Drucker Institute, The Wall Street Journal, Dow Jones, Fortune, Forbes, Fast Company and Barron’s.

Hologic’s sustainability achievements in fiscal year 2023 (FY23) included:

  • Devices and tests designed for early detection and treatment of breast and cervical cancers, sexually transmitted infections, uterine fibroids, abnormal uterine bleeding and other medical conditions. Hologic’s products were estimated to have impacted more than 250 million people worldwide in FY23.

  • The yearly Hologic Global Women’s Health Index, a survey that represents the perspectives of 97% of the female global population aged 15 and older. Data from the Index enables Hologic to lead strategic women’s health projects for the World Economic Forum and participate in the U.N. Women Generation Equality initiative.

  • Grants to more than 220 nonprofits around the world that advance women’s health, STEM education or social and racial equity. Hologic’s philanthropic initiatives include Project Health Equity, which aims to boost clinical care and research focused on medically underserved women.

  • Title sponsorship of the Women’s Tennis Association (WTA), the global leader in women’s professional sports. The partnership broke new ground with creation of the Hologic WTA Women’s Health Taskforce, which brings together medical and athletic performance experts to establish world-class wellness standards for active women on and off the tennis court. Hologic was selected by Laureus, the prestigious organization that advocates using sports to improve lives, as one of 30 brands worldwide that are making a meaningful societal impact via sports.

  • A deepened resolve to safeguard the environment, with targets to achieve a 15% reduction in non-hazardous/non-recyclable waste by 2025; attain a 30% reduction in Scope 1 and 2 greenhouse-gas emissions by 2030; reach 40% reliance on self-generated renewable energy by 2030 at Hologic-owned sites; and convert to 75% renewable electricity by 2035


About Hologic, Inc.

Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Its advancements include invention of the world’s first commercial 3D mammography system to find breast cancer earlier; leadership in testing for cervical cancer, sexually transmitted infections and respiratory illnesses; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding.

Forward-Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about Hologic’s sustainability efforts. There can be no assurance that these efforts will be successful, benefit the company and its stockholders, or improve over time. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any changes in expectations or events, conditions or circumstances on which any such data or statements are based.

Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries. 

Investor Contact

Ryan Simon

Vice President, Investor Relations
(+1) 858.410.8514



Media Contact

Hieu Phan

Director, Corporate Communications

(+1) 858.410.7953


Source: Hologic, Inc.